Trial intelligence / Profile preview

PK and Safety of Apetrol ES vs Megace in Healthy Male Volunteers

NCT02446353Phase 1Completed

Sponsor
LG Chem
Start
Apr 2010
Primary completion
Jun 2010
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of megestrol in anorexia nervosa (AN) and cachexia (4 arms), sponsored by LG Chem. Primary endpoints: Maximum Plasma Concentration at 120 hours and Area Under the Curve to Last Measurable Concentration at 120 hours. Started Apr 2010; status: completed.

02

Drugs

megestrol
03

Conditions

anorexia nervosa (AN)cachexia

Beyond the preview

Go deeper on NCT02446353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02446353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call